Dual chamber syringe with dual lumen intravenous set

The dual chamber syringe and multi-lumen IV set with a cracking pressure mechanism address the inefficiencies in low-flow fluid delivery by ensuring timely and efficient administration of medical fluids.

JP7591636B2Active Publication Date: 2024-11-28CAREFUSION 303 INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2023195625
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-10-11
Filing Date
2023-11-17
Publication Date
2024-11-28
Estimated Expiration
2039-10-10

AI Technical Summary

Technical Problem

Delivering medical fluids to fluid-restricted patients at low flow rates is often time-consuming and prone to delays due to traditional methods like cutting the IV line or using pumps for priming solutions.

Method used

A dual chamber syringe with a primary and secondary plunger system and a multi-lumen IV set featuring a valve housing with a cracking pressure mechanism, allowing controlled fluid flow and efficient priming and delivery of medical fluids.

Benefits of technology

The system enables timely and efficient delivery of medical fluids by integrating a dual chamber syringe with a multi-lumen IV set, reducing delays and improving fluid administration efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007591636000001
    Figure 0007591636000001
  • Figure 0007591636000002
    Figure 0007591636000002
  • Figure 0007591636000003
    Figure 0007591636000003
Patent Text Reader

Abstract

To provide a dual chamber syringe which can be connected to a dual lumen IV set in a fluid delivery system.SOLUTION: A dual chamber syringe may include an end wall and a primary plunger. The primary plunger may include a primary stopper. The primary stopper may form a primary chamber with the end wall. A secondary plunger may be mechanically related to the primary plunger. The secondary plunger may include a secondary stopper. The secondary stopper may form a secondary chamber with the primary stopper. A primary nozzle may extend from the end wall and may be in fluid communication with the primary chamber. A secondary nozzle may extend from the end wall and may be in fluid communication with the secondary chamber.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] Delivering medical fluids to fluid-limited patients often involves administering medical fluids intravenously from a fluid source at low flow rates via an intravenous (IV) set. Traditional methods often involve disconnecting the line and delivering an IV push, which can be time-consuming at such low flow rates. Other traditional methods may involve administering a priming solution via a pump prior to delivering the medical fluid to the fluid-limited patient, which can result in delays in not being able to administer the medical fluid to the fluid-limited patient in a timely manner. Summary of the Invention

[0002] The disclosed subject matter relates to a syringe. In certain embodiments, a dual chamber syringe includes a primary plunger having an end wall and a primary stopper, the primary stopper forming a primary chamber with the end wall, a secondary plunger in mechanical association with the primary plunger, the secondary plunger having a secondary stopper forming a secondary chamber with the primary stopper, a primary nozzle extending from the end wall in fluid communication with the primary chamber, and a secondary nozzle extending from the end wall in fluid communication with the secondary chamber.

[0003] In certain embodiments, a multi-lumen intravenous (IV) set includes an adapter having a primary duct and a secondary duct, a valve housing having a housing port and a housing passageway, a primary lumen in fluid communication with the primary duct and the housing port, a secondary lumen in fluid communication with the secondary duct and the housing port, and a valve disposed in the valve housing and having a cracking pressure configured to prevent fluid from flowing from the housing port to the housing passageway when pressure on the valve is lower than the cracking pressure and configured to allow fluid to flow from the housing port to the housing passageway when pressure on the valve is higher than the cracking pressure.

[0004] In certain embodiments, the fluid delivery system includes a dual chamber syringe having an end wall, a primary plunger having a primary stopper, the primary stopper forming a primary chamber with the end wall, a secondary plunger mechanically associated with the primary plunger, the secondary plunger having a secondary stopper forming a secondary chamber with the primary stopper, a primary nozzle extending from the end wall, the primary nozzle in fluid communication with the primary chamber, and a secondary nozzle extending from the end wall, the secondary nozzle in fluid communication with the secondary chamber; and an adapter having a primary port and a secondary port, the primary port fluidly coupled to the primary nozzle and the secondary port fluidly coupled to the secondary nozzle. the adapter includes a valve housing having a housing port and a housing passageway, a primary lumen in fluid communication with a primary duct disposed in the adapter and in fluid communication with the housing port, a secondary lumen in fluid communication with a secondary duct disposed in the adapter and in fluid communication with the housing port, and a valve disposed in the valve housing and having a cracking pressure, the valve being configured to prevent fluid from flowing from the housing port to the housing passageway when pressure on the valve is lower than the cracking pressure and configured to allow fluid to flow from the housing port to the housing passageway when pressure on the valve is higher than the cracking pressure.

[0005] The accompanying drawings are included to provide a further understanding of the subject technology, are incorporated in and constitute a part of this specification, illustrate aspects of the subject technology, and together with the specification explain the principles of the subject technology. [Brief description of the drawings]

[0006] [Figure 1] FIG. 2 is a side view of a dual chamber syringe with some portions cross-sectioned and broken away to show details, according to an embodiment of the present disclosure. [Diagram 2]FIG. 2 is a perspective view of the dual chamber syringe shown in FIG. 1 according to an embodiment of the present disclosure. [Diagram 3] 3 is a cross-sectional perspective view taken along line 3-3 of the dual chamber syringe of FIG. 1 showing an end wall of the syringe according to an embodiment of the present disclosure. [Figure 4] FIG. 2 is a detailed cross-sectional view of a primary plunger of the dual chamber syringe shown in FIG. 1 according to an embodiment of the present disclosure. [Diagram 5] FIG. 2 is a detailed cross-sectional perspective view of the dual chamber syringe of FIG. 1 with the activator in an unactivated state, according to an embodiment of the present disclosure. [Figure 6] FIG. 6 is a detailed plan view of a snap lock portion of the primary plunger shown in FIG. 5 according to an embodiment of the present disclosure. [Figure 7] FIG. 6 is a detailed perspective view of the activator shown in FIG. 5 in an actuated state, according to an embodiment of the present disclosure. [Figure 8] FIG. 1 is a plan view of a dual lumen intravenous (IV) set according to an embodiment of the present disclosure. [Figure 9] 9 is a plan view of the dual lumen IV set of FIG. 8 with some portions cross-sectioned and in phantom to show internal details of the dual lumen IV set according to an embodiment of the present disclosure. [Figure 10] FIG. 10 is a detailed perspective view of a dual lumen tube adapter of the dual lumen IV set of FIG. 9 according to an embodiment of the present disclosure. [Figure 11] FIG. 2 is a perspective view of a dual chamber syringe adapter according to an embodiment of the present disclosure. [Figure 12] FIG. 12 is a cross-sectional plan view taken along line 12-12 of FIG. 11 according to an embodiment of the present disclosure. [Figure 13] FIG. 2 is a perspective view of a flush syringe adapter according to an embodiment of the present disclosure. [Figure 14] FIG. 14 is a cross-sectional plan view taken along line 14-14 of FIG. 13 according to an embodiment of the present disclosure. [Figure 15]FIG. 1 is a plan view of a dual lumen IV set in use with a flush syringe in a pre-priming state with some portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 16] 16 is a plan view of the dual lumen IV set in use with the flush syringe of FIG. 15 in a post-priming state with some portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 17] 2 is a plan view of the dual chamber syringe of FIG. 1 in use with a vial in an unfilled state with portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 18] FIG. 18 is a top view of the dual chamber syringe of FIG. 17 in a filled state with the vial and dual chamber syringe adapter removed from the dual chamber syringe, with portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 19] 9 is a plan view of a fluid delivery system showing the dual chamber syringe of FIG. 1 in use with the dual lumen IV set of FIG. 8 prior to priming with a drug, with some portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 20] FIG. 20 is a plan view of the fluid delivery system of FIG. 19 after drug priming, showing a dual lumen IV set primed with drug, with portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 21] 20 is a plan view of the fluid delivery system of FIG. 19 in a pre-flushing state with portions cross-sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Figure 22] 20 is a plan view of the fluid delivery system of FIG. 19 in a post-flushing state with portions sectioned and broken away to show the internal fluid passages, according to an embodiment of the present disclosure. [Diagram 23]23 is a detailed view of a dual chamber syringe moving from the pre-flushing state shown in FIG. 21 to the post-flushing state shown in FIG. 22. [Figure 24] 23 is a detailed view of a dual chamber syringe moving from the pre-flushing state shown in FIG. 21 to the post-flushing state shown in FIG. 22. [Diagram 25] 23 is a detailed view of a dual chamber syringe moving from the pre-flushing state shown in FIG. 21 to the post-flushing state shown in FIG. 22. [Figure 26] 23 is a detailed view of a dual chamber syringe moving from the pre-flushing state shown in FIG. 21 to the post-flushing state shown in FIG. 22. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0007] In the following detailed description, specific details are set forth to enable an understanding of the subject technology. However, it will be apparent to one skilled in the art that the subject technology may be practiced without some of these specific details. In other instances, well-known structures and techniques are not shown in order to avoid obscuring the subject technology.

[0008] A phrase such as "aspect" does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. What is disclosed with respect to one aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as "one aspect" may refer to one or more aspects, and vice versa. A phrase such as "one embodiment" does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. What is disclosed with respect to one embodiment may apply to all configurations, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such as "one embodiment" may refer to one or more embodiments, and vice versa. A phrase such as "one embodiment" does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. What is disclosed with respect to one embodiment may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as "a configuration" may refer to one or more configurations, and vice versa.

[0009] 1-25 show a fluid delivery system including a dual-chamber syringe that is both a syringe and a pump and can be coupled to a dual-lumen intravenous (IV) set. The fluid delivery system is configured to remove a priming solution from the dual-lumen IV set and store it in the dual-chamber syringe, deliver a medication at a given flow rate, and administer the remaining medication in the dual-lumen IV set by returning the priming solution stored in the dual-chamber syringe to the dual-lumen IV set.

[0010] 1-6 illustrate an embodiment of a dual chamber syringe 110 of a fluid delivery system 100 (shown in FIG. 19). In some embodiments, the dual chamber syringe 110 includes a cylindrical syringe barrel 112, an end wall 114, and a syringe collar 116. The end wall 114 is disposed at a first end 118 of the syringe barrel 112, while the syringe collar 116 is disposed at a second end 120 of the syringe barrel 112 opposite the first end 118. The syringe collar 116 extends radially outward from the syringe barrel 112 just prior to the second end 120. The syringe barrel 112 includes a cylindrical interior chamber 122 extending between the end wall 114 and the syringe collar 116.

[0011] 3, the grooved channel 124 is recessed in an inner surface 126 of the end wall 114. The inner surface 126 faces and is disposed within the interior chamber 122. The channel 124 includes a notched end 128, a passage end 130, and a divot 132 disposed between the notched end 128 and the passage end 130. In some embodiments, the channel 124 includes opposing angled walls 134 extending between the notched end 128 and the divot 132, and between the divot 132 and the passage end 130. The notched end 128 is in fluid communication with a notch 136 disposed in the syringe barrel 112 at the intersection of the syringe barrel 112 and the end wall 114 just prior to the first end 118. The notch 136 extends axially inward from the end wall 114 within the interior chamber 122. The passage end 130 is in fluid communication with a passage 138 disposed through the end wall 114. In some aspects, the channel 124 extends along a portion of the diameter of the inner surface 126. The notch 136, the channel 124, and the passage 138 together form a flushing fluid flow path having features and functions described in more detail below.

[0012] The dual chamber syringe 110 also includes an inner tube 140. The inner tube 140 is disposed through the divot 132 and the inner surface 126 of the end wall 114 and extends axially inwardly within the inner chamber 122. The inner tube 140 terminates within the inner chamber 122 and is offset axially inwardly relative to the syringe collar 116. In some embodiments, the inner tube 140 extends substantially centrally through the divot 132 and the inner surface 126 of the end wall 114 and is centrally disposed within the inner chamber 122.

[0013] The dual chamber syringe 110 also includes a primary nozzle 142 and a secondary nozzle 144. Both the primary nozzle 142 and the secondary nozzle 144 extend axially outward from the end wall 114 and are disposed outwardly relative to the internal chamber 122. In some embodiments, the secondary nozzle 144 is centrally disposed in the end wall 114. The secondary nozzle 144 is coaxially aligned with and in fluid communication with the internal tube 140. The primary nozzle 142 is radially displaced (or offset) from the secondary nozzle 144 at the end wall 114. The primary nozzle 142 is in fluid communication with a primary chamber 145 of the internal chamber 122 via a passageway 138. A nozzle guide 143 also extends axially outward from the end wall 114 and surrounds both the primary nozzle 142 and the secondary nozzle 144 to facilitate connection of the dual chamber syringe 110 to other medical components. In some embodiments, the primary nozzle 142 and the secondary nozzle 144 are asymmetric to prevent backward or reverse coupling of the dual chamber syringe 110 to the dual lumen IV set (800). In some embodiments, the primary nozzle 142 and the secondary nozzle 144 are male Luer connectors. In other embodiments, the primary nozzle 142 is a male Luer connector and the secondary nozzle 144 is a needleless connector. In yet other embodiments, the primary nozzle 142 is a needleless connector and the secondary nozzle 144 is a male Luer connector.

[0014] Additionally, the dual chamber syringe 110 includes a primary plunger 146 and a secondary plunger 148. The primary plunger 146 is mechanically associated with the secondary plunger 148 such that the primary plunger 146 and the secondary plunger 148 are both configured to be received by and slidably move within the internal chamber 122. The primary plunger 146 includes a primary stopper 150, a primary head 152, and a rod 154 extending between the primary stopper 150 and the primary head 152. The primary stopper 150 is disposed at a first rod end 156 of the rod 154, and the primary head 152 is disposed at a second rod end 158 of the rod 154. The primary plunger 146 is disposed within the internal chamber 122 such that a primary chamber 159 is disposed between the primary stopper 150 and the inner surface 126 of the end wall 114. The primary plunger 146 includes a primary receiving bore 160 centrally disposed through the primary stopper 150. The rod 154 extends from the primary stopper 150 and includes a primary internal cavity 162 such that the primary internal cavity 162 aligns with the primary receiving bore 160. The primary receiving bore 160 and the primary internal cavity 162 are configured to slidably receive the inner tube 140 of the dual chamber syringe 110. In some embodiments, a first primary O-ring 164 is disposed in the primary receiving bore 160 such that the inner tube 140 is slidably and sealingly received by the first primary O-ring 164 and slidably received by the primary internal cavity 162. A chamber passage 166 is disposed through the rod 154 just prior to where the rod 154 and the primary stopper 150 intersect. In some embodiments, a second primary O-ring 168 is disposed about the primary stopper 150 for sealing engagement with the syringe barrel 112 .

[0015] The primary plunger 146 includes a locking member 170 disposed on the rod 154 between the primary internal cavity 162 and the primary head 152. With particular reference to FIG. 6, the locking member 170 includes opposing rod flanges 172. Each of the opposing rod flanges 172 includes a tapered tab 174 that projects radially outward and tapers axially toward the primary head 152. The opposing rod flanges 172 are depressible radially inward toward one another. The locking member 170 is mechanically associated with components of the secondary plunger 148 to releasably lock with the primary plunger 146, as will be described in more detail below.

[0016] The secondary plunger 148 includes a secondary stopper 176, a secondary head 178, and a body 180 extending between the secondary stopper 176 and the secondary head 178. The secondary stopper 176 is disposed at a first body end 182 of the body 180, and the secondary head 178 is disposed at a second body end 184 of the body 180. The body 180 includes a main section 186 and a neck section 188. In some embodiments, the main section 186 of the body 180 includes wings that include a plus sign (e.g., +) cross-section. The main section 186 transitions to the neck section 188 at a tapered section 190. In some embodiments, the neck section 188 includes a neck 192 disposed between the tapered section 190 and the secondary head 178. The neck 192 includes, in sequence from the tapered section 190 towards the secondary head 178, a first opposing plunger slot 194, a second opposing plunger slot 196, opposing activator lock slots 198, and opposing activator rest slots 200. Additionally, the secondary plunger 148 includes a secondary receiving bore 201 centrally disposed through the secondary stopper 176 and a head bore 202 centrally disposed through the secondary head 178. The secondary plunger 148 includes a secondary internal cavity 203 extending from the secondary receiving bore 201 in the secondary stopper 176 to the head bore 202 in the secondary head 178. The secondary receiving bore 201 and the secondary internal cavity 203 are configured to slidably receive the rod 154 of the primary plunger 146. In such a configuration within internal chamber 122, secondary chamber 199 of internal chamber 122 is disposed between secondary stopper 176 and primary stopper 150. In some embodiments, a first secondary O-ring 204 is disposed in secondary receiving hole 201 such that rod 154 is slidably and sealingly received by first secondary O-ring 204 and slidably received by secondary internal cavity 203. In some embodiments, a second secondary O-ring 205 is disposed about secondary stopper 176 for sealing engagement with syringe barrel 112.

[0017] Opposing locking flanges 206 project outwardly from neck 192 and extend axially along neck 192. A nub 208 projects radially inwardly from each of opposing locking flanges 206. The nub 208 is in registration with second opposing plunger slot 196. Opposing locking flanges 206 are configured to be forced radially inwardly toward one another such that nub 208 is received by second opposing plunger slot 196. Opposing locking flanges 206 are deformable and configured to be forced radially outwardly away from one another upon engagement with pin 209a. For example, pin 209a includes pull tab 209b to form catch 209c such that catch 209c is removably caught around neck 192 and disposed between opposing locking flanges 206 and neck 192 to urge opposing locking flanges 206 radially outward. When opposing locking flanges 206 are urged radially outward away from one another, nub 208 is held radially outward away from second opposing plunger slot 196.

[0018] The secondary plunger 148 includes a seat 210 centrally recessed in the secondary head 178 and aligned with the secondary internal cavity 203 and the head bore 202. The secondary plunger 148 also includes an activator 212. The activator 212 includes an activator body 214 and an activator head 216 attached to the activator body 214. The activator body 214 is substantially cylindrical and includes opposing activator flanges 218 formed thereon. Each of the opposing activator flanges 218 includes a tapered tab 220 that projects radially outward and tapers axially inward. The opposing activator flanges 218 are depressible radially inward toward one another. In an unactuated state of the activator 212, the tapered tabs 220 of the opposing activator flanges 218 are received by the opposing activator rest slots 200, and in an actuated state of the activator 212, the tapered tabs 220 are received by and remain in the opposing activator locking slots 198, while the activator body 214 is received by the head bore 202 such that the activator head 216 is received by the seat 210. Additionally, when the dual chamber syringe 110 is assembled, a resilient member 222 is disposed within the neck 192 between the activator head 216 and the primary head 152 of the primary plunger 146. The resilient member 222 is in an uncompressed state when the activator 212 is in an unactuated state and in a compressed state when the activator 212 is in an actuated state.

[0019] 8-10, the fluid delivery system 100 also includes a dual lumen intravenous (IV) set 800 that is connectable to the dual chamber syringe 110. Although the dual lumen IV set 800 is depicted with dashed lines to indicate a shortened length, it should be understood that the dual lumen IV set 800 can be any length, including, but not limited to, 1 meter, 2 meters, 3 meters, etc. The dual lumen IV set 800 includes a connector 810, a valve housing 812, a valve 814, a primary lumen 816, a secondary lumen 818, and an adapter 820. The connector 810 includes an outlet port 822, and a channel 824 fluidly connected to the outlet port 822. The connector 810 is configured to couple with a medical device, such as a catheter (not shown). Although the fluid delivery system 100 is shown with one dual lumen IV set 800, it is within the scope of this application for the fluid delivery system 100 to include multiple dual lumen IV sets to deliver multiple medications via multiple dual chamber syringes in one IV set. The channel 824 is also fluidly connected to a housing passage 826 disposed in the valve housing 812. In some embodiments, the channel 824 tapers from the housing passage 826 toward the outlet port 822. A housing port 828 is also disposed in the valve housing 812 and is in fluid communication with the housing passage 826. Respective ends of the primary lumen 816 and the secondary lumen 818 are received by and in fluid communication with the housing port 828. The other end of the primary lumen 816 is fluidly connected to a primary duct 830 disposed in the adapter 820, while the other end of the secondary lumen 818 is fluidly connected to a secondary duct 832 that is offset from the primary duct 830 and also disposed in the adapter 820.

[0020] Valve 814 is disposed in valve housing 812 and configured to seal housing port 828 from housing passageway 826 until pressure applied to valve 814 from housing port 828 reaches a predetermined cracking pressure at which fluid can flow from housing port 828 through valve 814 and into housing passageway 826. In some embodiments, valve 814 is a one-way valve, such as, but not limited to, a check valve or an anti-siphon valve. The predetermined cracking pressure can be selected to open at any predetermined pressure, such as, for example, 1 psi (pounds per square inch) or 0.5 psi (3.4 kPa).

[0021] The adapter 820 also includes a primary partition 834 and a secondary partition 836. The primary partition 834 is disposed in the primary duct 830. The primary partition 834 is configured to seal a primary port 838 of the adapter 820 disposed at an end of the primary duct 830 to prevent fluid from flowing from the primary port 838 to the primary duct 830 when not engaged with a medical device. However, when the adapter 820 is coupled to the dual chamber syringe 110, the primary nozzle 142 engages the primary partition 834 to allow fluid from the primary nozzle 142 to flow through the primary port 838 via the primary duct 830 to the primary lumen 816. The secondary partition 836 is disposed in the secondary duct 832 and configured to seal a secondary port 840 of the adapter 820 disposed at an end of the secondary duct 832 to prevent fluid from flowing from the secondary duct 832 to the secondary port 840 when not engaged with a medical device. However, when the adapter 820 is coupled to the dual chamber syringe 110, the secondary nozzle 144 engages the secondary bulkhead 836 to allow fluid from the secondary duct 832 to flow through the secondary port 840 to the secondary nozzle 144. Additionally, a secondary valve 842 is disposed in the secondary duct 832 to allow fluid to flow from the secondary lumen 818 through the secondary duct 832 to the secondary nozzle 144, but prevents fluid from flowing in the opposite direction from the secondary nozzle 144 to the secondary lumen 818. In some embodiments, the secondary valve 842 is a one-way valve, such as, but not limited to, a duckbill valve or a check valve. In some embodiments, the primary nozzle 142 and the secondary nozzle 144 are asymmetric such that the primary nozzle 142 is configured to be received only by the primary port 838 and not by the secondary port 840, while the secondary nozzle 144 is configured to be received only by the secondary port 840 and not by the primary port 838, preventing the dual chamber syringe 110 from being coupled to the dual lumen IV set 800 in the reverse or upside down orientation.

[0022] The adapter 820 also includes a ridge 844 disposed about the exterior and offset axially inward from the primary port 838 and the secondary port 840. The ridge 844 is configured to releasably snap-fit ​​or interlock with a seat 846 disposed within the nozzle guide 143 when the dual chamber syringe 110 and the dual lumen IV set 800 are mated together. In some embodiments, a first plurality of serrations 848 are disposed on the exterior of the adapter 820 to facilitate gripping when held in the hand.

[0023] 11-12, the fluid delivery system 100 also includes a dual chamber syringe adapter 1100. The dual chamber syringe adapter 1100 is matable to a dual chamber syringe 110 and a vial adapter 1110 (also shown in FIG. 17) that is mated to a vial 1112 (shown in FIG. 17). The dual chamber syringe adapter 1100 is configured to transfer fluid from the vial 1112 to the dual chamber syringe 110. The dual chamber syringe adapter 1100 includes a male connector 1114, a primary nozzle receiver 1116, a secondary nozzle receiver 1118, and a conduit 1120. In some embodiments, a second plurality of serrations 1121 are disposed on the exterior of the dual chamber syringe adapter 1100 to facilitate gripping when held in the hand. A conduit 1120 is disposed through the dual chamber syringe adapter 1100 and fluidly couples the male connector 1114 to the primary nozzle receiver 1116. A nozzle seat 1122 is disposed in the secondary nozzle receiver 1118 in sealing engagement with the secondary nozzle 144 to prevent any fluid from flowing through the secondary nozzle 144. The dual chamber syringe adapter 1100 also includes a cap 1124 hingedly coupled to the male connector 1114 for removably capping or closing the male connector 1114. In some embodiments, the male connector 1114 is a male Luer connector. The male connector 1114 is configured to mate with the female connector of the vial adapter 1110. The primary nozzle receiver 1116 is configured to matingly receive the primary nozzle 142 of the dual chamber syringe 110, and the secondary nozzle receiver 1118 is configured to matingly receive the secondary nozzle 144 of the dual chamber syringe 110, while the adapter ridge 1126 disposed on the exterior of the dual chamber syringe adapter 1100 removably snap-fits or couples with the seat 846.When the dual chamber syringe adapter 1100 is coupled to the dual chamber syringe 110, fluid from the vial 1112 can be drawn through the vial adapter 1110, the male connector 1114, and the conduit 1120 through the primary nozzle 142 and into the primary chamber 159.

[0024] 13 and 14, the fluid delivery system 100 also includes a flush syringe adapter 1300. The flush syringe adapter 1300 is coupleable to a flush syringe 1310 (shown in FIG. 15) and an adapter 820 of the dual lumen IV set 800. The flush syringe adapter 1300 is configured to transfer fluid from the flush syringe 1310 to prime the dual lumen IV set 800 with saline. The flush syringe adapter 1300 includes a primary adapter nozzle 1312, a secondary adapter nozzle 1314, a syringe guide 1316, a female connector 1318, a primary passageway 1320, and a secondary passageway 1322. In some embodiments, a third plurality of serrations 1324 are disposed on the exterior of the flush syringe adapter 1300 to facilitate gripping when held in the hand. Syringe guide 1316 surrounds primary adapter nozzle 1312 and secondary adapter nozzle 1314 to facilitate coupling of flush syringe adapter 1300 to dual lumen IV set 800 such that primary adapter nozzle 1312 is received by primary port 838 of adapter 820 and secondary adapter nozzle 1314 is received by secondary port 840. In some embodiments, primary adapter nozzle 1312 and secondary adapter nozzle 1314 are asymmetric such that primary adapter nozzle 1312 is configured to be received only by primary port 838 and not by secondary port 840, while secondary adapter nozzle 1314 is configured to be received only by secondary port 840 and not by primary port 838, preventing coupling of flush syringe adapter 1300 to dual lumen IV set 800 in the reverse or upside down orientation. In some embodiments, the primary adapter nozzle 1312 and the secondary adapter nozzle 1314 are male Luer connectors. In other embodiments, the primary adapter nozzle 1312 is a male Luer connector and the secondary adapter nozzle 1314 is a needleless connector. In yet other embodiments, the primary adapter nozzle 1312 is a needleless connector and the secondary adapter nozzle 1314 is a male Luer connector.

[0025] The primary passageway 1320 is disposed between and fluidly couples the primary adapter nozzle 1312 and an adapter port 1328 disposed in the female connector 1318. In some embodiments, the female connector 1318 is a female luer connector. The female connector 1318 is configured to mate with a male connector of the flush syringe 1310. In some embodiments, the male connector of the flush syringe 1310 is a male luer connector. The secondary passageway 1322 is disposed between and fluidly couples the secondary adapter nozzle 1314 and the vent hole 1330. The liquidphobic element 1332 is disposed in the secondary passageway 1322 and configured to allow air to enter from the secondary adapter nozzle 1314 and escape through the vent hole 1330, but prevents the liquid fluid from flowing out of the vent hole 1330 when the liquidphobic element 1332 comes into contact with a liquid fluid (e.g., saline from the flush syringe 1310).

[0026] 15 shows the dual lumen IV set 800 in use with flush syringe 1310 before priming, and FIG. 16 shows the dual lumen IV set 800 in use with flush syringe 1310 after priming. For priming of the dual lumen IV set 800, which may be performed at a patient's bedside, the flush syringe adapter 1300 is coupled to the dual lumen IV set 800 such that the primary adapter nozzle 1312 and the secondary adapter nozzle 1314 are received by the primary port 838 and the secondary port 840, respectively, and the adapter seat 1326 removably snap-fits with the raised portion 844 of the adapter 820. With the flush syringe adapter 1300 coupled to the dual lumen IV set 800, the saline pre-filled dual chamber syringe adapter 1100 is coupled to the flush syringe adapter 1300 by the female connector 1318. The flush syringe 1310 delivers saline through the adapter port 1328 and the primary passageway 1320 to the primary port 838 and the primary duct 830. The saline flows from the primary duct 830 through the primary lumen 816 until it reaches the housing port 828 and the valve 814. When the pressure on the valve 814 is below a predetermined cracking pressure, the saline flows through the secondary lumen 818 and the secondary valve 842. During the flow process, air within the dual lumen IV set 800 is forced out of the vent 1330 through the hydrophobic element 1332, but when the saline contacts the hydrophobic element 1332, the hydrophobic element 1332 prevents the saline from flowing further. Because saline is prevented from flowing past the hydrophobic element 1332, the remainder of the dual lumen IV set 800 is primed with saline. After the dual lumen IV set 800 is fully primed, it can be coupled to a medical device, such as a catheter.With the dual lumen IV set 800 coupled to the catheter, the hydrophobic element 1332 prevents saline from flowing, so that the pressure on the valve 814 exceeds a predetermined cracking pressure, causing the valve 814 to flush the remainder of the saline in the flush syringe 1310 by allowing saline to flow through the housing passageway 826, out the outlet port 822 and into the catheter. The flush syringe adapter 1300, along with the flush syringe 1310, are then disconnected from the dual lumen IV set 800.

[0027] 17 shows the dual chamber syringe 110 in use with a vial 1112 before filling, and FIG. 18 shows the dual chamber syringe 110 after filling with a vial 1112 with the dual chamber syringe adapter 1100 disconnected. The pin 209a is inserted around the neck 192 and presses the opposing locking flanges 206 radially outwardly, such that the nubs 208 are held radially outwardly away from the second opposing plunger slots 196. With the nubs 208 so positioned, the tapered tabs 174 of the locking member 170 are removably received in the second opposing plunger slots 196 to lock the primary plunger 146 to the secondary plunger 148. With the activator 212 in an unactuated state, the tapered tabs 220 of the opposing activator flanges 218 are received by and remain in the opposing activator rest slots 200 such that the resilient member 222 is in an uncompressed state between the primary head 152 of the primary plunger 146 and the activator head 216. This configuration locks the primary plunger 146 to the secondary plunger 148 such that the primary stopper 150 is offset from the secondary stopper 176 a predetermined distance that can be preselected according to the particular amount desired to prefill the secondary chamber 199. The dual chamber syringe 110 is prefilled with saline in the secondary chamber 199 as shown in FIG.

[0028] During use, such as in a pharmaceutical environment, the activator 212 of the dual chamber syringe 110 is actuated by pushing the activator head 216 axially inward, causing the tapered tabs 220 of the opposing activator flanges 218 to be forced radially inward toward one another, out of the opposing activator rest slots 200, and lockedly received by the opposing activator locking slots 198, while the activator head 216 is received by the seat 210. In this configuration, the resilient member 222 is in a compressed state between the primary head 152 of the primary plunger 146 and the activator head 216 in the seat 210. Leaving the resilient member 222 in an uncompressed state prior to use can increase the useful life of the dual chamber syringe 110. After actuation of activator 212, nozzle guide 143 facilitates coupling of dual chamber syringe 110 to dual chamber syringe adapter 1100 such that primary nozzle 142 is matingly inserted into primary nozzle receiver 1116, secondary nozzle 144 is matingly inserted into secondary nozzle receiver 1118, and adapter ridge 1126 removably snap-fits or interfaces with seat 846. With secondary nozzle 144 received by secondary nozzle receiver 1118 and seated in nozzle seat 1122, saline is prevented from accidentally flowing out of secondary chamber 199 during transfer of fluid from vial 1112 to dual chamber syringe 110.

[0029] With the dual chamber syringe adapter 1100 coupled to the dual chamber syringe 110, the male connector 1114 is coupled to the vial adapter 1110 which is coupled to the vial 1112. When the primary plunger 146 is engaged with the secondary plunger 148, pulling the secondary head 178 axially away from the syringe collar 116 draws the fluid (e.g., medication) within the vial 1112 through the dual chamber syringe adapter 1100 and the primary nozzle 142 via the passageway 138 and into the primary chamber 159 without disturbing the saline within the secondary chamber 199, the inner tube 140, and the primary inner cavity 162. Once the desired amount of medication has been drawn into the primary chamber 159, the dual chamber syringe adapter 1100 can be disconnected from the dual chamber syringe 110, as shown in FIG.

[0030] 19 illustrates the dual chamber syringe 110 of the fluid delivery system 100 in use with a dual lumen IV set 800 prior to priming with a drug. The dual lumen IV set 800 is primed with saline and is fluidly coupled to a catheter 1910. The dual lumen IV set 800 is also fluidly coupled to the dual chamber syringe 110 which is mechanically engaged with a syringe pump 1920. The syringe pump 1920 also mechanically engages the secondary head 178 to selectively control the axial movement of the secondary plunger 148 while positively supporting the syringe barrel 112.

[0031] The dual chamber syringe 110 and dual lumen IV set 800 transition from a pre-priming condition to a post-priming condition as shown in FIG. 20. This transition involves disengaging the pin 209a from the neck 192, causing the opposing locking flanges 206 to move radially toward one another and the nubs 208 to engage the tapered tabs 174 of the locking member 170, disengaging the tapered tabs 174 from the second opposing plunger slots 196. With the secondary head 178 held in place by the syringe pump 1920, the disengagement or unseating of the tapered tabs 174 from the second opposing plunger slots 196 allows the compressed resilient member 222 to push the primary head 152, which in turn pushes the primary plunger 146 axially toward the end wall 114. As the primary plunger 146 is forced axially toward the end wall 114, the drug in the primary chamber 159 is forced through the passageway 138, out the primary nozzle 142, into the primary duct 830, and into the primary lumen 816. At the same time, because the pressure on the valve 814 is below the predetermined cracking pressure, the drug displaces the primed saline within the dual lumen IV set 800, which exits the secondary port 840, through the secondary nozzle 144, through the internal tube 140, the primary internal cavity 162, and the chamber passageway 166 to fill the secondary chamber 199. The primary plunger 146 continues to prime the dual lumen IV set 800 with drug until the tapered tab 174 is received by and retained in the first opposing plunger slot 194, thereby preventing the resilient member 222 from further pushing the primary plunger 146.

[0032] The dual chamber syringe 110 and dual lumen IV set 800 transition from a state after priming with drug to a state before flushing, as shown in FIG. 21. This transition involves the syringe pump 1920 moving the secondary head 178 of the secondary plunger 148 axially toward the end wall 114 to deliver drug remaining in the primary chamber 159 through the passageway 138 and the primary nozzle 142 to the primary duct 830 and primary lumen 816. Because the secondary valve 842 prevents saline from flowing from the secondary chamber 199 to the secondary lumen 818, as the secondary plunger 148 is moved axially, the pressure on the valve 814 increases and exceeds the predetermined cracking pressure, so that as the secondary plunger 148 moves axially, drug is forced through the valve 814, through the channel 824 and the exit port 822 into the housing passageway 826 and into the catheter 1910. As the secondary plunger 148 is moved axially toward the end wall 114 , the tapered tab 174 unseats from the first opposing plunger slot 194 and is moved toward the second opposing plunger slot 196 .

[0033] Once the primary stopper 150 abuts the inner surface 126 of the end wall 114, the dual chamber syringe 110 and dual lumen IV set 800 transition from a pre-flushing state to a post-flushing state, as shown in FIG 22. This transition is illustrated in FIGs 23-26. FIG 23 shows the pre-flushing state, with the primary stopper 150 abutting the inner surface 126 of the end wall 114 and medication in the channel 124 and notch 136. The second primary O-ring 168 seals the notch 136 and prevents medication from entering the secondary chamber 199. During the transition, as secondary plunger 148 continues to move axially toward end wall 114, pressure increases on second primary O-ring 168, causing saline in secondary chamber 199 to be forced through second primary O-ring 168, through notch 136, and into channel 124, thereby forcing the drug through passageway 138 and into primary nozzle 142. Syringe pump 1920 continues to move secondary plunger 148 axially, causing saline to be forced out of secondary chamber 199, displacing the drug out of channel 124. In this manner, the saline forces the drug out of primary lumen 816, causing all of the drug to be delivered to the patient and primed dual lumen IV set 800 with saline.

[0034] In some embodiments, the dual chamber syringe is preloaded with saline in the secondary chamber 199. In some embodiments, the secondary chamber 199 is configured to receive priming solution from the dual lumen IV set 800, but is not used for pre-flushing. In some embodiments, the secondary chamber 199 is configured to stop the secondary plunger 148 when receiving priming solution from the dual lumen IV set 800, indicating that the dual chamber syringe 110 is ready to inject medication. In some embodiments, the fluid delivery system 100 includes a valve lock to prevent fluid from being delivered to the patient during priming. In some embodiments, the priming volume can be selected in 0.1 mL increments. In some embodiments, the secondary plunger 148 includes a plunger handle base that rotates to allow the plunger rod to rotate out of engagement while maintaining friction with the syringe pump paddle. In some embodiments, the secondary plunger 148 is automatically released at a specific plunger depth instead of using pin 209a so that the injection is not interrupted and no human interaction is required. In some embodiments, the fluid delivery system 100 includes a vent to vent residual air bubbles through a breathable filter. In some embodiments, the fluid delivery system 100 is configured to preset and limit the priming volume by a pin that limits the travel of the plunger.

[0035] (Description of the subject technology as a clause) For convenience, various illustrative aspects of the disclosure are described as numbered clauses (1, 2, 3, etc.). These are provided as examples and are not intended to limit the subject technology. Figures and reference numerals are identified below for purposes of example and explanation only, and the clauses are not intended to be limited by these identifications.

[0036] Clause 1) A dual chamber syringe having an end wall, a primary plunger having a primary stopper, the primary stopper forming a primary chamber with the end wall, a secondary plunger mechanically associated with the primary plunger, the secondary plunger having a secondary stopper forming a secondary chamber with the primary stopper, a primary nozzle extending from the end wall, the primary nozzle in fluid communication with the primary chamber, and a secondary nozzle extending from the end wall, the secondary nozzle in fluid communication with the secondary chamber.

[0037] Clause 2) The dual chamber syringe of clause 1, wherein the secondary nozzle extends centrally from the end wall.

[0038] Clause 3) The dual chamber syringe of clause 2, wherein the primary nozzle is radially displaced (or offset) from the secondary nozzle.

[0039] Clause 4) A dual-chamber syringe according to any one of clauses 1 to 3, wherein the primary nozzle and the secondary nozzle are asymmetric.

[0040] Clause 5) A dual chamber syringe described in any one of clauses 1 to 4, further comprising a nozzle guide extending from the end wall and surrounding the primary nozzle and the secondary nozzle.

[0041] Clause 6) A dual chamber syringe as described in any one of clauses 1 to 5, wherein the primary plunger is lockable to the secondary plunger.

[0042] Clause 7) A dual chamber syringe according to any one of clauses 1 to 6, wherein the end wall has a channel.

[0043] Clause 8) A dual chamber syringe as described in clause 7, wherein when the dual chamber syringe is transitioning from a pre-flushing state to a flushing state, the secondary chamber is fluidly connected to the primary nozzle via the channel.

[0044] Clause 9) A dual chamber syringe described in any one of clauses 1 to 8, wherein the secondary nozzle is fluidly connected to the secondary chamber via an internal tube extending from the end wall.

[0045] Clause 10) A dual chamber syringe as described in clause 9, wherein the inner tube is received by a primary inner cavity of the primary plunger.

[0046] Clause 11) A multi-lumen intravenous (IV) set comprising: an adapter having a primary duct and a secondary duct; a valve housing having a housing port and a housing passage; a primary lumen in fluid communication with the primary duct and the housing port; a secondary lumen in fluid communication with the secondary duct and the housing port; and a valve disposed in the valve housing and having a cracking pressure, the valve being configured to prevent fluid from flowing from the housing port to the housing passage when a pressure on the valve is lower than the cracking pressure, and configured to allow fluid to flow from the housing port to the housing passage when a pressure on the valve is higher than the cracking pressure.

[0047] Clause 12) A multi-lumen IV set as described in clause 11, wherein the primary lumen is in fluid communication with the secondary lumen when the pressure on the valve is lower than the cracking pressure.

[0048] Clause 13) A multi-lumen IV set described in clause 11 or 12, further comprising a primary partition (primary septum) disposed in the primary duct and a secondary partition (secondary septum) disposed in the secondary duct.

[0049] Clause 14) A multi-lumen IV set as described in Clause 13, wherein the primary partition is configured to seal a primary port disposed in the primary duct to prevent fluid from flowing from the primary port to the primary duct when not engaged with a medical device, and the primary partition is configured to allow fluid to flow from the primary port to the primary duct when engaged with the medical device, and the secondary partition is configured to seal a secondary port disposed in the secondary duct to prevent fluid from flowing from the secondary port to the secondary duct when not engaged with the medical device, and the secondary partition is configured to allow fluid to flow from the secondary port to the secondary duct when engaged with the medical device.

[0050] Clause 15) The multi-lumen IV set described in Clause 14, further comprising a secondary valve disposed in the secondary duct, the secondary valve configured to allow fluid to flow from the secondary lumen to the secondary port and to prevent fluid from flowing from the secondary port to the secondary lumen.

[0051] Clause 16) A multi-lumen IV set as described in clause 15, wherein the secondary valve is a check valve.

[0052] Clause 17) A multi-lumen IV set described in clauses 14 to 16, wherein the primary port and the secondary port are asymmetric.

[0053] Clause 18) A dual chamber syringe having an end wall, a primary plunger having a primary stopper, the primary stopper forming a primary chamber with the end wall, a secondary plunger mechanically associated with the primary plunger, the secondary plunger having a secondary stopper forming a secondary chamber with the primary stopper, a primary nozzle extending from the end wall, the primary nozzle in fluid communication with the primary chamber, and a secondary nozzle extending from the end wall, the secondary nozzle in fluid communication with the secondary chamber; and an adapter having a primary port and a secondary port, the primary port fluidly coupled to the primary nozzle and the secondary port fluidly coupled to the secondary nozzle; and a valve housing having a housing passageway, a primary lumen in fluid communication with a primary duct disposed in the adapter and in fluid communication with the housing port, a secondary lumen in fluid communication with a secondary duct disposed in the adapter and in fluid communication with the housing port, and a valve disposed in the valve housing, the valve having a cracking pressure, the valve being configured to prevent fluid from flowing from the housing port to the housing passageway when pressure on the valve is lower than the cracking pressure, and configured to allow fluid to flow from the housing port to the housing passageway when pressure on the valve is higher than the cracking pressure.

[0054] Clause 19) The fluid delivery system of clause 18, wherein the primary plunger has a locking member configured to releasably lock the primary plunger to the secondary plunger.

[0055] Clause 20) A fluid delivery system as described in clause 18 or 19, wherein a secondary valve is disposed in the secondary duct so as to allow fluid to flow from the secondary lumen to the secondary port and to prevent fluid from flowing from the secondary port to the secondary lumen.

[0056] The foregoing description is provided to enable one skilled in the art to practice the various configurations described herein. Although the subject technology has been specifically described with reference to various figures and configurations, it should be understood that these are for illustrative purposes only and should not be taken as limiting the scope of the subject technology.

[0057] There may be many other ways to implement the subject technology. The various functions and elements described herein may be partitioned differently than shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other configurations. Thus, those skilled in the art may make numerous modifications and variations to the subject technology without departing from the scope of the subject technology.

[0058] As used herein, the phrase "at least one" preceding a series of items, along with the terms "and" or "or" separating any of those items, modifies the list as a whole rather than each listed element (i.e., each item). The phrase "at least one" does not require the selection of at least one of each listed item; rather, the phrase can mean including at least one of any one of the items, and / or at least one of any combination of the items, and / or at least one of each of the items. By way of example, the phrase "at least one of A, B, and C" or "at least one of A, B, or C" refers, respectively, to only A, only B, or only C, any combination of A, B, and C, and / or at least one of each of A, B, and C.

[0059] Moreover, to the extent that the terms "include," "have," and the like are used in the detailed description or the claims, such terms are intended to be inclusive in the same manner as the term "comprise" is interpreted when used as a transition term in a claim. The word "exemplary" is used herein to mean "serving as an example, instance, or illustration." Any embodiment described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other embodiments.

[0060] Reference to an element in the singular is not intended to mean "one and only one" unless specifically stated otherwise, but rather "one or more." The term "several" refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the subject technology. Furthermore, nothing disclosed herein is intended to be made available to the public, regardless of whether such disclosure is expressly recited in the description above.

[0061] Although specific aspects and examples of the subject technology have been described, they have been presented by way of example only and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications that are within the scope and spirit of the subject technology.

Claims

1. an adapter having a primary duct and a secondary duct; a valve housing having a housing port and a housing passage; a primary lumen in fluid communication with the primary duct and the housing port; a secondary lumen in fluid communication with the secondary duct and the housing port; a valve disposed within the valve housing, the valve having a cracking pressure and configured to prevent fluid from flowing from the housing port to the housing passage when pressure on the valve is less than the cracking pressure and configured to allow fluid to flow from the housing port to the housing passage when pressure on the valve is greater than the cracking pressure; A multi-lumen intravenous (IV) set having:

2. 2. The multi-lumen IV set of claim 1, wherein the primary lumen is in fluid communication with the secondary lumen when the pressure on the valve is less than the cracking pressure.

3. 10. The multi-lumen IV set of claim 1, further comprising a primary bulkhead disposed in the primary duct and a secondary bulkhead disposed in the secondary duct.

4. the primary bulkhead is configured to seal a primary port disposed in the primary duct to prevent fluid from flowing from the primary port to the primary duct when not engaged with a medical device, and configured to allow fluid to flow from the primary port to the primary duct when engaged with the medical device; and 4. The multi-lumen IV set of claim 3, wherein the secondary barrier is configured to seal a secondary port disposed in the secondary duct to prevent fluid from flowing from the secondary port to the secondary duct when not engaged with the medical device, and configured to allow fluid to flow from the secondary port to the secondary duct when engaged with the medical device.

5. 5. The multi-lumen IV set of claim 4, further comprising a secondary valve disposed in the secondary duct, the secondary valve configured to allow fluid to flow from the secondary lumen to the secondary port and to prevent fluid from flowing from the secondary port to the secondary lumen.

6. 6. The multi-lumen IV set of claim 5, wherein the secondary valve is a check valve.

7. The multi-lumen IV set of claim 4 , wherein the primary port and the secondary port are asymmetric.

Citation Information

Patent Citations

  • Fluid transfer device and method of use

    JP2015211873A

  • Multi-lumen catheter with detachable locking hub

    US20040122418A1